撒哈拉以南非洲地区的癌症试验：使研究与护理相协调。
Cancer trials in sub-Saharan Africa: Aligning research and care.
作者信息
Gopal Satish
机构信息
Malawi Cancer Consortium, Lilongwe, Malawi.
UNC Project-Malawi, Lilongwe, Malawi.
出版信息
PLoS Med. 2017 Jul 10;14(7):e1002351. doi: 10.1371/journal.pmed.1002351. eCollection 2017 Jul.
Abstract
Satish Gopal discusses the challenges of deliverable cancer care and cancer trials in sub-Saharan Africa as well as a potential framework for overcoming these challenges.
摘要
萨蒂什·戈帕尔探讨了撒哈拉以南非洲地区提供可及癌症护理和开展癌症试验所面临的挑战，以及克服这些挑战的潜在框架。
相似文献
1
Cancer trials in sub-Saharan Africa: Aligning research and care.撒哈拉以南非洲地区的癌症试验：使研究与护理相协调。
PLoS Med. 2017 Jul 10;14(7):e1002351. doi: 10.1371/journal.pmed.1002351. eCollection 2017 Jul.
2
Affordability of Cancer Drugs in Sub-Saharan Africa: Effects of Pricing on Needless Loss of Life.撒哈拉以南非洲地区癌症药物的可负担性：定价对不必要生命损失的影响。
JAMA Oncol. 2017 Oct 1;3(10):1301-1302. doi: 10.1001/jamaoncol.2017.0479.
3
Breast Cancer in Sub-Saharan Africa: Challenges and Opportunities to Reduce Mortality.撒哈拉以南非洲地区的乳腺癌：降低死亡率面临的挑战与机遇
Oncologist. 2016 Jun;21(6):739-44. doi: 10.1634/theoncologist.2015-0429. Epub 2016 Apr 18.
4
Therapeutic misconception and clinical trials in sub-Saharan Africa: a review.撒哈拉以南非洲地区的治疗误解与临床试验：综述
East Afr Med J. 2009 Jun;86(6):291-9. doi: 10.4314/eamj.v86i6.54142.
5
The REVAMP trial to evaluate HIV resistance testing in sub-Saharan Africa: a case study in clinical trial design in resource limited settings to optimize effectiveness and cost effectiveness estimates.评估撒哈拉以南非洲地区艾滋病毒耐药性检测的REVAMP试验：资源有限环境下临床试验设计的案例研究，以优化有效性和成本效益估计。
HIV Clin Trials. 2017 Jul;18(4):149-155. doi: 10.1080/15284336.2017.1349028. Epub 2017 Jul 18.
6
Challenges and opportunities in cancer control in Africa: a perspective from the African Organisation for Research and Training in Cancer.非洲癌症控制面临的挑战和机遇：来自非洲癌症研究和培训组织的观点。
Lancet Oncol. 2013 Apr;14(4):e142-51. doi: 10.1016/S1470-2045(12)70482-5.
7
Contemporary issues on the epidemiology and antiretroviral adherence of HIV-infected adolescents in sub-Saharan Africa: a narrative review.撒哈拉以南非洲地区感染艾滋病毒青少年的流行病学和抗逆转录病毒药物依从性的当代问题：一项叙述性综述。
J Int AIDS Soc. 2015 Sep 16;18(1):20049. doi: 10.7448/IAS.18.1.20049. eCollection 2015.
8
Population-based rates, timing, and causes of maternal deaths, stillbirths, and neonatal deaths in south Asia and sub-Saharan Africa: a multi-country prospective cohort study.南亚和撒哈拉以南非洲地区基于人群的孕产妇死亡、死产和新生儿死亡的发生率、时间和原因：一项多国前瞻性队列研究。
Lancet Glob Health. 2018 Dec;6(12):e1297-e1308. doi: 10.1016/S2214-109X(18)30385-1. Epub 2018 Oct 22.
9
Participant views and experiences of participating in HIV research in sub-Saharan Africa: a qualitative systematic review.撒哈拉以南非洲地区参与者对参与艾滋病病毒研究的看法和经历：一项定性系统评价
JBI Database System Rev Implement Rep. 2015 Jun 12;13(5):330-420. doi: 10.11124/jbisrir-2015-2051.
10
Improvement of pathology in sub-Saharan Africa.改善撒哈拉以南非洲的病理学状况。
Lancet Oncol. 2013 Apr;14(4):e152-7. doi: 10.1016/S1470-2045(12)70598-3.
引用本文的文献
1
Globalisation of industry-sponsored clinical trials for breast, lung and colon cancer research: trends, threats and opportunities.乳腺癌、肺癌和结肠癌研究的行业资助临床试验全球化：趋势、威胁与机遇。
BMJ Oncol. 2023 Sep 30;2(1):e000101. doi: 10.1136/bmjonc-2023-000101. eCollection 2023.
2
Using context-specific evidence to inform resource-stratified cancer guidelines: A call for a new approach.利用特定背景证据为资源分层癌症指南提供信息：呼吁采用新方法。
Cancer. 2025 Jan 1;131(1):e35573. doi: 10.1002/cncr.35573. Epub 2024 Sep 22.
3
Evaluating the Knowledge Change Before and After Continuing Cancer Education in Malawian Nurses.评估马拉维护士继续癌症教育前后的知识变化。
J Cancer Educ. 2023 Oct;38(5):1624-1628. doi: 10.1007/s13187-023-02310-y. Epub 2023 May 20.
4
Action for Increasing Diversity, Market Access, and Capacity in Oncology Registration Trials-Is Africa the Answer? Report From a Satellite Session of the Accelerating Anti-Cancer Agent Development and Validation Workshop.促进肿瘤登记试验中多样性、市场准入和能力的行动——非洲是答案吗？在加速抗癌药物研发和验证研讨会上的卫星会议报告。
JCO Glob Oncol. 2022 Jun;8:e2200117. doi: 10.1200/GO.22.00117.
5
Innovative Strategies for Developing Biomarker-Informed Cancer Clinical Trials to Accelerate Progress in Precision Oncology in Sub-Saharan Africa.创新策略制定生物标志物指导的癌症临床试验，以加速撒哈拉以南非洲精准肿瘤学的进展。
Am Soc Clin Oncol Educ Book. 2022 Apr;42:1-9. doi: 10.1200/EDBK_349955.
6
Treatment outcomes of esophageal cancer in Eastern Africa: protocol of a multi-center, prospective, observational, open cohort study.东非食管癌的治疗结果：一项多中心、前瞻性、观察性、开放队列研究的方案。
BMC Cancer. 2022 Jan 19;22(1):82. doi: 10.1186/s12885-021-09124-5.
7
Oncology Clinical Trials in Africa: Partnering for Quality.非洲肿瘤临床研究：合作提升质量。
JCO Glob Oncol. 2021 Apr;7:572-576. doi: 10.1200/JGO.19.00315.
8
Breast Cancer Clinical Trials: The Landscape at the Uganda Cancer Institute and Lessons Learned.乳腺癌临床试验：乌干达癌症研究所的现状及经验教训。
JCO Glob Oncol. 2021 Jan;7:127-132. doi: 10.1200/GO.20.00185.
9
ARETTA: Assessing Response to Neoadjuvant Taxotere and Subcutaneous Trastuzumab in Nigerian Women With HER2-Positive Breast Cancer: A Study Protocol.阿雷塔：评估尼日利亚HER2阳性乳腺癌女性对新辅助多西他赛和皮下注射曲妥珠单抗的反应：一项研究方案。
JCO Glob Oncol. 2020 Jul;6:983-990. doi: 10.1200/GO.20.00043.
10
Landscape of Oncology Clinical Trials in Africa.非洲肿瘤学临床试验概况
JCO Glob Oncol. 2020 Jun;6:932-941. doi: 10.1200/JGO.19.00189.
本文引用的文献
1
Plasma Epstein-Barr virus DNA for pediatric Burkitt lymphoma diagnosis, prognosis and response assessment in Malawi.马拉维用于儿童伯基特淋巴瘤诊断、预后及反应评估的血浆爱泼斯坦-巴尔病毒DNA
Int J Cancer. 2017 Jun 1;140(11):2509-2516. doi: 10.1002/ijc.30682. Epub 2017 Mar 24.
2
Effect of a Proposed Trastuzumab Biosimilar Compared With Trastuzumab on Overall Response Rate in Patients With ERBB2 (HER2)-Positive Metastatic Breast Cancer: A Randomized Clinical Trial.拟用曲妥珠单抗生物类似药对比曲妥珠单抗治疗 ERBB2（HER2）阳性转移性乳腺癌患者的总缓解率：一项随机临床试验。
JAMA. 2017 Jan 3;317(1):37-47. doi: 10.1001/jama.2016.18305.
3
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study.全球、区域和国家癌症发病率、死亡率、生命损失年数、失能生存年数以及 32 种癌症组别的伤残调整生命年数，1990 年至 2015 年：全球疾病负担研究的系统分析。
JAMA Oncol. 2017 Apr 1;3(4):524-548. doi: 10.1001/jamaoncol.2016.5688.
4
The use of anthracyclines in the treatment of endemic Burkitt lymphoma.蒽环类药物在地方性伯基特淋巴瘤治疗中的应用。
Br J Haematol. 2017 Jun;177(6):984-990. doi: 10.1111/bjh.14440. Epub 2016 Nov 28.
5
Subtyping sub-Saharan esophageal squamous cell carcinoma by comprehensive molecular analysis.通过全面的分子分析对撒哈拉以南地区食管鳞状细胞癌进行亚型分类。
JCI Insight. 2016 Oct 6;1(16):e88755. doi: 10.1172/jci.insight.88755.
6
Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma.基于中期PET-CT扫描指导的晚期霍奇金淋巴瘤适应性治疗
N Engl J Med. 2016 Jun 23;374(25):2419-29. doi: 10.1056/NEJMoa1510093.
7
Population pharmacokinetics of Reditux™, a biosimilar Rituximab, in diffuse large B-cell lymphoma.生物类似药利妥昔单抗Reditux™在弥漫性大B细胞淋巴瘤中的群体药代动力学
Cancer Chemother Pharmacol. 2016 Aug;78(2):353-9. doi: 10.1007/s00280-016-3083-x. Epub 2016 Jun 21.
8
Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma.索拉非尼在晚期肝细胞癌中的疗效
Oncologist. 2016 Sep;21(9):1113-20. doi: 10.1634/theoncologist.2015-0478. Epub 2016 May 16.
9
Factors influencing survival among Kenyan children diagnosed with endemic Burkitt lymphoma between 2003 and 2011: A historical cohort study.2003年至2011年间确诊为地方性伯基特淋巴瘤的肯尼亚儿童的生存影响因素：一项历史性队列研究。
Int J Cancer. 2016 Sep 15;139(6):1231-40. doi: 10.1002/ijc.30170. Epub 2016 May 18.
10
US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emission Tomography Imaging: Southwest Oncology Group S0816.美国采用早期中期氟脱氧葡萄糖-正电子发射断层扫描成像对Ⅲ至Ⅳ期霍奇金淋巴瘤进行适应性治疗的多中心试验：西南肿瘤协作组S0816。
J Clin Oncol. 2016 Jun 10;34(17):2020-7. doi: 10.1200/JCO.2015.63.1119. Epub 2016 Apr 11.
Zotero 插件